nach oben

Pituitary

Erschienen in:

26.12.2017

Management of nonfunctioning pituitary adenomas (NFAs): observation

verfasst von: Wenyu Huang, Mark E. Molitch

Erschienen in: Pituitary | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Clinically nonfunctioning pituitary adenomas (NFAs) range from those causing significant hypothalamic/pituitary dysfunction and visual field compromise due to their large size to those being completely asymptomatic. In the absence of hypersecretion, hypopituitarism or visual field defects, patients with NFAs may be followed by periodic surveillance using MRI to detect tumor enlargement. In some cases, endocrine tests are also needed during observation to discover new pituitary dysfunction. Enlargement of NFAs without treatment occurs in about 10% of microadenomas and 23% of macroadenomas. Growth of a pituitary incidentaloma, the development of visual field defects or the development of hypopituitarism are potential indications for surgery during follow up.

Saeger W, Ludecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S (2007) Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol 156:203–216CrossRefPubMed

Molitch ME (2009) Pituitary tumours: pituitary incidentalomas. Best Pract Res Clin Endocrinol Metab 23:667–675CrossRefPubMed

Chambers EF, Turski PA, LaMasters D, Newton TH (1982) Regions of low density in the contrast-enhanced pituitary gland: normal and pathologic processes. Radiology 144:109–113CrossRefPubMed

Elster AD (1993) Modern imaging of the pituitary. Radiology 187:1–14CrossRefPubMed

Freda PU, Wardlaw SL, Post KD (1996) Unusual causes of sellar/parasellar masses in a large transsphenoidal surgical series. J Clin Endocrinol Metab 81:3455–3459PubMed

Naidich MJ, Russell EJ (1999) Current approaches to imaging of the sellar region and pituitary. Endocrinol Metab Clin North Am 28:45–79CrossRefPubMed

Doraiswamy PM, Potts JM, Axelson DA, Husain MM, Lurie SN, Na C et al (1992) MR assessment of pituitary gland morphology in healthy volunteers: age- and gender-related differences. Am J Neuroradiol 13:1295–1299PubMed

Chanson P, Daujat F, Young J, Bellucci A, Kujas M, Doyon D et al (2001) Normal pituitary hypertrophy as a frequent cause of pituitary incidentaloma: a follow-up study. J Clin Endocrinol Metab 86:3009–3015CrossRefPubMed

Elster AD, Chen MY, Williams DW, 3rd, Key LL (1990) Pituitary gland: MR imaging of physiologic hypertrophy in adolescence. Radiology 174:681–685CrossRefPubMed

10.

Tsunoda A, Okuda O, Sato K (1997) MR height of the pituitary gland as a function of age and sex: especially physiological hypertrophy in adolescence and in climacterium. AJNR Am J Neuroradiol 18:551–554PubMed

11.

Esteves C, Neves C, Augusto L, Menezes J, Pereira J, Bernardes I et al (2015) Pituitary incidentalomas: analysis of a neuroradiological cohort. Pituitary 18:777–781CrossRefPubMed

12.

Molitch ME (2012) Management of incidentally found nonfunctional pituitary tumors. Neurosurg Clin N Am 23:543–553CrossRefPubMed

13.

Molitch ME (2014) Nonfunctioning pituitary tumors. Handb Clin Neurol 124:167–184CrossRefPubMed

14.

Reincke M, Allolio B, Saeger W, Menzel J, Winkelmann W (1990) The incidentaloma of the pituitary gland: is neurosurgery required? JAMA 263:2772–2776CrossRefPubMed

15.

Donovan LE, Corenblum B (1995) The natural history of the pituitary incidentaloma. Arch Intern Med 155:181–183CrossRefPubMed

16.

Nishizawa S, Ohta S, Yokoyama T, Uemura K (1998) Therapeutic strategy for incidentally found pituitary tumors (pituitary incidentalomas). Neurosurgery 43:1344–1348 (discussion 1348–1350)PubMed

17.

Feldkamp J, Santen R, Harms E, Aulich A, Modder U, Scherbaum WA (1999) Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas—results of a prospective study. Clin Endocrinol 51:109–113CrossRef

18.

Igarashi T, Saeki N, Yamaura A (1999) Long-term magnetic resonance imaging follow-up of asymptomatic sellar tumors—their natural history, surgical indications. Neurol Med Chir 39:592–598 (discussion 598–599)CrossRef

19.

Sanno N, Oyama K, Tahara S, Teramoto A, Kato Y (2003) A survey of pituitary incidentaloma in Japan. Eur J Endocrinol 149:123–127CrossRefPubMed

20.

Day PF, Guitelman M, Artese R, Fiszledjer L, Chervin A, Vitale NM et al (2004) Retrospective multicentric study of pituitary incidentalomas. Pituitary 7:145–148CrossRefPubMed

21.

Arita K, Tominaga A, Sugiyama K, Eguchi K, Iida K, Sumida M et al (2006) Natural course of incidentally found nonfunctioning pituitary adenoma, with special reference to pituitary apoplexy during follow-up examination. J Neurosurg 104:884–891CrossRefPubMed

22.

Dekkers OM, Hammer S, de Keizer RJ, Roelfsema F, Schutte PJ, Smit JW et al (2007) The natural course of nonfunctioning pituitary macroadenomas. Eur J Endocrinol 156:217–224CrossRefPubMed

23.

Karavitaki N, Collison K, Halliday J, Byrne JV, Price P, Cudlip S et al (2007) What is the natural history of nonoperated nonfunctioning pituitary adenomas? Clin Endocrinol 67:938–943CrossRef

24.

Anagnostis P, Admidou F, Polyzos SA, Efstathiadou Z, Panagiotou A, Kita M (2011) Pituitary incidentalomas: a single-centre experience. Int J Clin Pract 65(2):172–177

25.

Aghakhani K, Kadivar M, Kazemi-Esfeh S, Zamani N, Moradi M, Sanaei-Zadeh H (2011) Prevalence of pituitary incidentaloma in the Iranian cadavers. Indian J Pathol Microbiol 54:692–694PubMed

26.

Lenders N, Ikeuchi S, Russell AW, Ho KK, Prins JB, Inder WJ (2015) Longitudinal evaluation of the natural history of conservatively managed nonfunctioning pituitary adenomas. Clin Endocrinol 84(2):222–228CrossRef

27.

Iglesias P, Arcano K, Trivino V, Garcia-Sancho P, Diez JJ, Villabona C et al (2017) Prevalence, clinical features, and natural history of incidental clinically nonfunctioning pituitary adenomas. Horm Metab Res 49:654–659CrossRefPubMed

28.

Fernandez-Balsells MM, Murad MH, Barwise A, Gallegos-Orozco JF, Paul A, Lane MA et al (2011) Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and metaanalysis. J Clin Endocrinol Metab 96:905–912CrossRefPubMed

29.

Honegger J, Zimmermann S, Psaras T, Petrick M, Mittelbronn M, Ernemann U et al (2008) Growth modelling of nonfunctioning pituitary adenomas in patients referred for surgery. Eur J Endocrinol 158:287–294CrossRefPubMed

30.

Galland F, Vantyghem MC, Cazabat L, Boulin A, Cotton F, Bonneville JF et al (2015) Management of nonfunctioning pituitary incidentaloma. Ann Endocrinol 76:191–200CrossRef

31.

Freda PU, Beckers AM, Katznelson L, Molitch ME, Montori VM, Post KD et al (2011) Pituitary incidentaloma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96:894–904CrossRefPubMedPubMedCentral

32.

Chanson P, Raverot G, Castinetti F, Cortet-Rudelli C, Galland F, Salenave S (2015) Management of clinically nonfunctioning pituitary adenoma. Ann Endocrinol 76:239–247CrossRef

33.

Messerer M, Dubourg J, Raverot G, Bervini D, Berhouma M, George I et al (2013) Nonfunctioning pituitary macro-incidentalomas benefit from early surgery before becoming symptomatic. Clin Neurol Neurosurg 115:2514–2520CrossRefPubMed

34.

Scangas GA, Laws ER Jr (2014) Pituitary incidentalomas. Pituitary 17:486–491CrossRefPubMed

35.

Orija IB, Weil RJ, Hamrahian AH (2012) Pituitary incidentaloma. Best Pract Res Clin Endocrinol Metab 26:47–68CrossRefPubMed

36.

Arafah BM (1986) Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 62:1173–1179CrossRefPubMed

37.

Comtois R, Beauregard H, Somma M, Serri O, Aris-Jilwan N, Hardy J (1991) The clinical and endocrine outcome to trans-sphenoidal microsurgery of nonsecreting pituitary adenomas. Cancer 68:860–866CrossRefPubMed

38.

Losa M, Mortini P, Barzaghi R, Ribotto P, Terreni MR, Marzoli SB et al (2008) Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence. J Neurosurg 108:525–532CrossRefPubMed

39.

Nomikos P, Ladar C, Fahlbusch R, Buchfelder M (2004) Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas—a study on 721 patients. Acta Neurochir 146:27–35CrossRefPubMed

40.

Gsponer J, De Tribolet N, Deruaz JP, Janzer R, Uske A, Mirimanoff RO et al (1999) Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients. Medicine 78:236–269CrossRefPubMed

41.

Losa M, Donofrio CA, Barzaghi R, Mortini P (2013) Presentation and surgical results of incidentally discovered nonfunctioning pituitary adenomas: evidence for a better outcome independently of other patients’ characteristics. Eur J Endocrinol 169:735–742CrossRefPubMed

42.

Ambrosi B, Barbetta L, Dall’Asta C, Libe R (2001) Metamorphosis of a nonfunctioning pituitary adenoma to Cushing’s disease. Pituitary 4:127–128CrossRefPubMed

43.

Vaughan NJ, Laroche CM, Goodman I, Davies MJ, Jenkins JS (1985) Pituitary Cushing’s disease arising from a previously non-functional corticotrophic chromophobe adenoma. Clin Endocrinol 22:147–153CrossRef

Titel: Management of nonfunctioning pituitary adenomas (NFAs): observation
verfasst von: Wenyu Huang
Mark E. Molitch
Publikationsdatum: 26.12.2017
Verlag: Springer US
Erschienen in: Pituitary / Ausgabe 2/2018
Print ISSN: 1386-341X
Elektronische ISSN: 1573-7403
DOI: https://doi.org/10.1007/s11102-017-0856-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Management of nonfunctioning pituitary adenomas (NFAs): observation

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2018

Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas

Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma)

Non-functioning pituitary adenomas, not all the same and certainly not boring!

How non-functioning pituitary adenomas can affect health-related quality of life: a conceptual model and literature review

Management of nonfunctioning pituitary tumors: radiotherapy

Apoplexy in nonfunctioning pituitary adenomas

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin